All-trans-retinoic acid activates the pro-invasive Src-YAP-Interleukin 6 axis in triple-negative MDA-MB-231 breast cancer cells while cerivastatin reverses this action

Abstract All-trans-retinoic acid (RA), the active metabolite of vitamin A, can reduce the malignant phenotype in some types of cancer and paradoxically also can promote cancer growth and invasion in others. For instance, it has been reported that RA induces tumor suppression in tumor xenografts of M...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Belén Mezquita, Pau Mezquita, Montserrat Pau, Laura Gasa, Lourdes Navarro, Mireia Samitier, Miquel Pons, Cristóbal Mezquita
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/2a1dc9fb90a2496e9e3925c46c9cd114
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2a1dc9fb90a2496e9e3925c46c9cd114
record_format dspace
spelling oai:doaj.org-article:2a1dc9fb90a2496e9e3925c46c9cd1142021-12-02T15:08:25ZAll-trans-retinoic acid activates the pro-invasive Src-YAP-Interleukin 6 axis in triple-negative MDA-MB-231 breast cancer cells while cerivastatin reverses this action10.1038/s41598-018-25526-12045-2322https://doaj.org/article/2a1dc9fb90a2496e9e3925c46c9cd1142018-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-25526-1https://doaj.org/toc/2045-2322Abstract All-trans-retinoic acid (RA), the active metabolite of vitamin A, can reduce the malignant phenotype in some types of cancer and paradoxically also can promote cancer growth and invasion in others. For instance, it has been reported that RA induces tumor suppression in tumor xenografts of MDA-MB-468 breast cancer cells while increasing tumor growth and metastases in xenografts of MDA-MB-231 breast cancer cells. The signaling pathways involved in the pro-invasive action of retinoic acid remain mostly unknown. We show here that RA activates the pro-invasive axis Src-YAP-Interleukin 6 (Src-YAP-IL6) in triple negative MDA-MB-231 breast cancer cells, yielding to increased invasion of these cells. On the contrary, RA inhibits the Src-YAP-IL6 axis of triple-negative MDA-MB-468 cells, which results in decreased invasion phenotype. In both types of cells, inhibition of the Src-YAP-IL6 axis by the Src inhibitor PP2 drastically reduces migration and invasion. Src inhibition also downregulates the expression of a pro-invasive isoform of VEGFR1 in MDA-MB-231 breast cancer cells. Furthermore, interference of YAP nuclear translocation using the statin cerivastatin reverses the upregulation of Interleukin 6 (IL-6) and the pro-invasive effect of RA on MDA-MB-231 breast cancer cells and also decreases invasion and viability of MDA-MB-468 breast cancer cells. These results altogether suggest that RA induces pro-invasive or anti-invasive actions in two triple-negative breast cancer cell lines due to its ability to activate or inhibit the Src-YAP-IL6 axis in different cancer cells. The pro-invasive effect of RA can be reversed by the statin cerivastatin.Belén MezquitaPau MezquitaMontserrat PauLaura GasaLourdes NavarroMireia SamitierMiquel PonsCristóbal MezquitaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-8 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Belén Mezquita
Pau Mezquita
Montserrat Pau
Laura Gasa
Lourdes Navarro
Mireia Samitier
Miquel Pons
Cristóbal Mezquita
All-trans-retinoic acid activates the pro-invasive Src-YAP-Interleukin 6 axis in triple-negative MDA-MB-231 breast cancer cells while cerivastatin reverses this action
description Abstract All-trans-retinoic acid (RA), the active metabolite of vitamin A, can reduce the malignant phenotype in some types of cancer and paradoxically also can promote cancer growth and invasion in others. For instance, it has been reported that RA induces tumor suppression in tumor xenografts of MDA-MB-468 breast cancer cells while increasing tumor growth and metastases in xenografts of MDA-MB-231 breast cancer cells. The signaling pathways involved in the pro-invasive action of retinoic acid remain mostly unknown. We show here that RA activates the pro-invasive axis Src-YAP-Interleukin 6 (Src-YAP-IL6) in triple negative MDA-MB-231 breast cancer cells, yielding to increased invasion of these cells. On the contrary, RA inhibits the Src-YAP-IL6 axis of triple-negative MDA-MB-468 cells, which results in decreased invasion phenotype. In both types of cells, inhibition of the Src-YAP-IL6 axis by the Src inhibitor PP2 drastically reduces migration and invasion. Src inhibition also downregulates the expression of a pro-invasive isoform of VEGFR1 in MDA-MB-231 breast cancer cells. Furthermore, interference of YAP nuclear translocation using the statin cerivastatin reverses the upregulation of Interleukin 6 (IL-6) and the pro-invasive effect of RA on MDA-MB-231 breast cancer cells and also decreases invasion and viability of MDA-MB-468 breast cancer cells. These results altogether suggest that RA induces pro-invasive or anti-invasive actions in two triple-negative breast cancer cell lines due to its ability to activate or inhibit the Src-YAP-IL6 axis in different cancer cells. The pro-invasive effect of RA can be reversed by the statin cerivastatin.
format article
author Belén Mezquita
Pau Mezquita
Montserrat Pau
Laura Gasa
Lourdes Navarro
Mireia Samitier
Miquel Pons
Cristóbal Mezquita
author_facet Belén Mezquita
Pau Mezquita
Montserrat Pau
Laura Gasa
Lourdes Navarro
Mireia Samitier
Miquel Pons
Cristóbal Mezquita
author_sort Belén Mezquita
title All-trans-retinoic acid activates the pro-invasive Src-YAP-Interleukin 6 axis in triple-negative MDA-MB-231 breast cancer cells while cerivastatin reverses this action
title_short All-trans-retinoic acid activates the pro-invasive Src-YAP-Interleukin 6 axis in triple-negative MDA-MB-231 breast cancer cells while cerivastatin reverses this action
title_full All-trans-retinoic acid activates the pro-invasive Src-YAP-Interleukin 6 axis in triple-negative MDA-MB-231 breast cancer cells while cerivastatin reverses this action
title_fullStr All-trans-retinoic acid activates the pro-invasive Src-YAP-Interleukin 6 axis in triple-negative MDA-MB-231 breast cancer cells while cerivastatin reverses this action
title_full_unstemmed All-trans-retinoic acid activates the pro-invasive Src-YAP-Interleukin 6 axis in triple-negative MDA-MB-231 breast cancer cells while cerivastatin reverses this action
title_sort all-trans-retinoic acid activates the pro-invasive src-yap-interleukin 6 axis in triple-negative mda-mb-231 breast cancer cells while cerivastatin reverses this action
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/2a1dc9fb90a2496e9e3925c46c9cd114
work_keys_str_mv AT belenmezquita alltransretinoicacidactivatestheproinvasivesrcyapinterleukin6axisintriplenegativemdamb231breastcancercellswhilecerivastatinreversesthisaction
AT paumezquita alltransretinoicacidactivatestheproinvasivesrcyapinterleukin6axisintriplenegativemdamb231breastcancercellswhilecerivastatinreversesthisaction
AT montserratpau alltransretinoicacidactivatestheproinvasivesrcyapinterleukin6axisintriplenegativemdamb231breastcancercellswhilecerivastatinreversesthisaction
AT lauragasa alltransretinoicacidactivatestheproinvasivesrcyapinterleukin6axisintriplenegativemdamb231breastcancercellswhilecerivastatinreversesthisaction
AT lourdesnavarro alltransretinoicacidactivatestheproinvasivesrcyapinterleukin6axisintriplenegativemdamb231breastcancercellswhilecerivastatinreversesthisaction
AT mireiasamitier alltransretinoicacidactivatestheproinvasivesrcyapinterleukin6axisintriplenegativemdamb231breastcancercellswhilecerivastatinreversesthisaction
AT miquelpons alltransretinoicacidactivatestheproinvasivesrcyapinterleukin6axisintriplenegativemdamb231breastcancercellswhilecerivastatinreversesthisaction
AT cristobalmezquita alltransretinoicacidactivatestheproinvasivesrcyapinterleukin6axisintriplenegativemdamb231breastcancercellswhilecerivastatinreversesthisaction
_version_ 1718388112100425728